ACTRN12623000427673进行中（未招募）Unknown
Effects of lutein/ zeaxanthin on eye health, eye strain, sleep quality, and attention in high electronic screen users: a randomised, double-blind, placebo-controlled study
Clinical Research Australia0 个研究点目标入组 70 人开始时间: 2023年4月28日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •1. Generally healthy adults (male and female) 18 to 65 years
- •2. Spends at least 6 hours a day viewing a screen at a distance of 1 metre or less
- •3. Non-smoker
- •4. BMI between 18 and 30 kg/m2
- •5. No plan to commence new treatments over the study period
- •6. Willing to maintain current diet, exercise, and supplement regimen during the study period
- •7. If wearing spectacles for vision, best corrected visual acuity must be 6/6
- •8. Understand, willing and able to comply with all study procedures
- •9. Willing to provide a personally signed and dated informed consent form detailing all pertinent aspects of the trial.
排除标准
- •1. Ocular disorders including but not limited to cataract, corneal diseases, ocular surface disorders, glaucoma, retinal disease, and myopia (except mild to moderate severity)
- •2. Undergone eye surgery in the past
- •3. Wear contact lenses more than 3 days a week
- •4. Suffering from a recently diagnosed or uncontrolled medical condition including but not limited to: diabetes, hyper/hypotension, cardiovascular disease, gastrointestinal disease, gallbladder disease/gallstones/biliary disease, rheumatoid arthritis or another autoimmune disease, asthma, seasonal allergies, or endocrine disease.
- •5. Diagnosis of medical or psychiatric conditions including but not limited to: psychiatric disorder (other than mild-to-moderate depression or anxiety), neurological disease (Parkinson’s, Alzheimer’s disease, intracranial haemorrhage, head or brain injury), or cancer/malignancy
- •6. Regular medication intake including but not limited to steroid medications, hormone replacement therapy, eye drops, antihistamines, beta-blockers, or tricyclic antidepressants.
- •7. Change in medication in the last 3 months or an expectation to change during the study duration
- •8. Taking vitamins, herbal, or other nutritional supplements that are reasonably expected to influence study measures.
- •9. Current or 12-month history of illicit drug abuse
- •10. Alcohol intake greater than 14 standard drinks per week
- •11. Women who are pregnant, breastfeeding, or intend to fall pregnant in the next 6 months
- •12. Any significant surgeries over the last year
- •13. Planned major lifestyle change in the next 6 months
研究者
相似试验
已完成
不适用
The effects of Lutein/Zeaxanthin supplementation on cognitive function in adults with self-reported mild cognitive complaintsMild cognitive impairmentNeurological - Other neurological disordersAlternative and Complementary Medicine - Other alternative and complementary medicineMental Health - Other mental health disordersACTRN12621000038897Clinical Research Australia96
已完成
不适用
Effect of Lutein, Zeaxanthin supplements on human.Healthy peopleJPRN-UMIN000025699aboratory of Systematic Forest and Forest Products Science, Faculty of Agriculture, Kyushu University40
已完成
不适用
Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Degeneration - The Gut-Retina-axis StudyAge-Related Macular DegenerationNCT06391411Azienda Ospedaliero-Universitaria Careggi45
终止
不适用
Effects of Lutein on Visual FunctionHealthyNutrition PoorNCT03113864Kemin Foods LC14
已完成
不适用
Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients With Age-related Macular DegenerationAge-Related Macular DegenerationNCT00879671Medical University of Vienna126